AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,663,961 | +9.9% | 89,575 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,423,900 | -37.9% | 89,575 | -50.0% | 0.01% | +12.5% |
| Q3 2022 | $3,901,944 | -21.3% | 179,150 | -1.2% | 0.01% | -11.1% |
| Q2 2022 | $4,959,055 | -35.2% | 181,350 | -20.6% | 0.01% | -18.2% |
| Q1 2022 | $7,651,700 | +87.2% | 228,400 | +93.7% | 0.01% | +10.0% |
| Q4 2021 | $4,088,000 | +0.9% | 117,900 | -9.2% | 0.01% | -9.1% |
| Q3 2021 | $4,053,000 | -57.1% | 129,900 | -50.0% | 0.01% | -21.4% |
| Q2 2021 | $9,448,000 | +637.0% | 259,800 | +786.7% | 0.01% | +250.0% |
| Q1 2021 | $1,282,000 | +11.4% | 29,300 | -15.4% | 0.00% | 0.0% |
| Q3 2020 | $1,151,000 | -53.2% | 34,636 | -58.7% | 0.00% | -20.0% |
| Q2 2020 | $2,462,000 | +9.1% | 83,800 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $2,256,000 | -10.0% | 83,800 | +12.6% | 0.01% | +20.0% |
| Q4 2019 | $2,508,000 | +4.0% | 74,400 | +15.5% | 0.01% | 0.0% |
| Q3 2019 | $2,412,000 | +1.3% | 64,400 | +17.9% | 0.01% | 0.0% |
| Q2 2019 | $2,382,000 | – | 54,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |